Citadel Advisors »

Seres Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $193k 138k 1.40
2023-09-30 $864k 363k 2.38
2023-06-30 $1.9M 401k 4.79
2023-03-31 $3.7M 658k 5.67
2022-12-31 $450k 80k 5.60
2022-06-30 $712k 208k 3.43
2022-03-31 $2.2M 304k 7.12
2021-12-31 $4.2M 504k 8.33
2021-09-30 $1.5M 216k 6.96
2021-06-30 $9.4M 395k 23.86
2021-03-31 $8.8M 429k 20.60
2020-12-31 $8.2M 336k 24.51
2020-09-30 $3.2M 114k 28.31
2020-06-30 $666k 140k 4.76
2020-03-31 $161k 45k 3.56
2019-12-31 $168k 49k 3.45
2019-09-30 $72k 18k 4.02
2019-06-30 $213k 66k 3.24
2019-03-31 $109k 16k 6.87
2018-12-31 $200k 44k 4.51
2018-09-30 $239k 31k 7.62
2018-06-30 $183k 21k 8.63
2018-03-31 $1.0M 137k 7.33
2017-12-31 $1.4M 138k 10.14
2017-06-30 $456k 40k 11.33
2017-03-31 $233k 21k 11.28
2016-12-31 $117k 12k 9.90
2016-09-30 $1.5M 123k 12.28